Impact of Blood Transfusion on Short- and Long-Term Mortality in Patients With ST-Segment Elevation Myocardial Infarction

JACC: Cardiovascular Interventions

Volumn 2, Issue 1, 2009, Pages 46-53

  Shishehbor, Mehdi H ^a   Madhwal, Surabhi ^a   Rajagopal, Vivek ^b   Hsu, Amy ^a   Kelly, Peter ^a   Gurm, Hitinder S ^c   Kapadia, Samir R ^a   Lauer, Michael S ^d   Topol, Eric J ^e  

^a LERNER RESEARCH INSTITUTE   (United States)

^b PIEDMONT HEART INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

blood transfusion; long term outcome; propensity analysis; ST segment elevation myocardial infarction

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; ST SEGMENT ELEVATION; ACUTE CORONARY SYNDROME; CLINICAL TRIAL; CONFIDENCE INTERVAL; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; UNITED STATES;

ACUTE CORONARY SYNDROME; AGED; ANEMIA; BLOOD TRANSFUSION; CONFIDENCE INTERVALS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; KAPLAN-MEIER ESTIMATE;

EID: 58249097192     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.09.011     Document Type: Article

References (44)

1. Arant C.B., Wessel T.R., Olson M.B., et al. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol 43 (2004) 2009-2014
2. Bindra K., Berry C., Rogers J., et al. Abnormal haemoglobin levels in acute coronary syndromes. QJM 99 (2006) 851-862
3. Nikolsky E., Aymong E.D., Halkin A., et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 44 (2004) 547-553
4. Vis M.M., Sjauw K.D., van der Schaaf R.J., et al. Prognostic value of admission hemoglobin levels in ST-segment elevation myocardial infarction patients presenting with cardiogenic shock. Am J Cardiol 99 (2007) 1201-1202
5. Eikelboom J.W., Mehta S.R., Anand S.S., Xie C., Fox K.A., and Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114 (2006) 774-782
6. Spencer F.A., Moscucci M., Granger C.B., et al. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?. Circulation 116 (2007) 2793-2801
7. Hebert P.C., and Fergusson D.A. Do transfusions get to the heart of the matter?. JAMA 292 (2004) 1610-1612
8. Rao S.V., Jollis J.G., Harrington R.A., et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292 (2004) 1555-1562
9. Wu W.C., Rathore S.S., Wang Y., Radford M.J., and Krumholz H.M. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345 (2001) 1230-1236
10. Yang X., Alexander K.P., Chen A.Y., et al. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 46 (2005) 1490-1495
11. Corwin H.L., and Carson J.L. Blood transfusion-when is more really less?. N Engl J Med 356 (2007) 1667-1669
12. Allen L.A., O'Donnell C.J., Camargo Jr. C.A., Giugliano R.P., and Lloyd-Jones D.M. Comparison of long-term mortality across the spectrum of acute coronary syndromes. Am Heart J 151 (2006) 1065-1071
13. Alexander K.P., Chen A.Y., Roe M.T., et al. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA 294 (2005) 3108-3116
14. Lerman A., Holmes D.R., Herrmann J., and Gersh B.J. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?. Eur Heart J 28 (2007) 788-797
15. Figueras J., Monasterio Y., Lidon R.M., Nieto E., and Soler-Soler J. Thrombin formation and fibrinolytic activity in patients with acute myocardial infarction or unstable angina: in-hospital course and relationship with recurrent angina at rest. J Am Coll Cardiol 36 (2000) 2036-2043
16. Manten A., de Winter R.J., Minnema M.C., et al. Procoagulant and proinflammatory activity in acute coronary syndromes. Cardiovasc Res 40 (1998) 389-395
17. Merlini P.A., Bauer K.A., Oltrona L., et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 90 (1994) 61-68
18. Minnema M.C., Peters R.J., de Winter R., et al. Activation of clotting factors XI and IX in patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol 20 (2000) 2489-2493
19. Fitzgerald R.D., Martin C.M., Dietz G.E., Doig G.S., Potter R.F., and Sibbald W.J. Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats. Crit Care Med 25 (1997) 726-732
20. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 335 (1996) 775-782
21. Hebert P.C., Wells G., Blajchman M.A., et al., Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340 (1999) 409-417
22. Rosenbaum P.R. Discussing hidden bias in observational studies. Ann Intern Med 115 (1991) 901-905
23. Vincent J.L., Baron J.F., Reinhart K., et al. Anemia and blood transfusion in critically ill patients. JAMA 288 (2002) 1499-1507
24. Rao S.V., O'Grady K., Pieper K.S., et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 96 (2005) 1200-1206
25. Hardy J.F. Transfusion in elderly patients with myocardial infarction. N Engl J Med 346 (2002) 779-782
26. Sabatine M.S., Morrow D.A., Giugliano R.P., et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111 (2005) 2042-2049
27. Kershenovich S., Modiano M., and Ewy G.A. Markedly decreased coronary blood flow in secondary polycythemia. Am Heart J 123 (1992) 521-523
28. Lowe G.D., and Forbes C.D. Blood rheology and thrombosis. Clin Haematol 10 (1981) 343-367
29. Turczyński B., Slowińska L., Szczesny S., et al. The whole blood and plasma viscosity changes in course of acute myocardial infarction. Pol Arch Med Wewn 108 (2002) 971-978
30. Bunn H.F., May M.H., Kocholaty W.F., and Shields C.E. Hemoglobin function in stored blood. J Clin Invest 48 (1969) 311-321
31. Sugerman H.J., Davidson D.T., Vibul S., Delivoria-Papadopoulos M., Miller L.D., and Oski F.A. The basis of defective oxygen delivery from stored blood. Surg Gynecol Obstet 131 (1970) 733-741
32. Valtis D.J. Defective gas-transport function of stored red blood-cells. Lancet 266 (1954) 119-124
33. Casutt M., Seifert B., Pasch T., Schmid E.R., Turina M.I., and Spahn D.R. Factors influencing the individual effects of blood transfusions on oxygen delivery and oxygen consumption. Crit Care Med 27 (1999) 2194-2200
34. Dietrich K.A., Conrad S.A., Hebert C.A., Levy G.L., and Romero M.D. Cardiovascular and metabolic response to red blood cell transfusion in critically ill volume-resuscitated nonsurgical patients. Crit Care Med 18 (1990) 940-944
35. Fransen E., Maessen J., Dentener M., Senden N., and Buurman W. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 116 (1999) 1233-1239
36. La Celle P.L. Alteration of deformability of the erythrocyte membrane in stored blood. Transfusion 9 (1969) 238-245
37. Offner P.J. Age of blood: does it make a difference?. Crit Care 8 Suppl 2 (2004) S24-S26
38. Corwin H.L., Gettinger A., Pearl R.G., et al. The CRIT study: anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 32 (2004) 39-52
39. Leal-Noval S.R., Jara-Lopez I., Garcia-Garmendia J.L., et al. Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients. Anesthesiology 98 (2003) 815-822
40. Licker M., Mariethoz E., Costa M.J., and Morel D. Cardioprotective effects of acute isovolemic hemodilution in a rat model of transient coronary occlusion. Crit Care Med 33 (2005) 2302-2308
41. Reimers R.C., Sutera S.P., and Joist J.H. Potentiation by red blood cells of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms. Blood 64 (1984) 1200-1206
42. Bennett-Guerrero E., Veldman T.H., Doctor A., et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A 104 (2007) 17063-17068
43. Reynolds J.D., Ahearn G.S., Angelo M., Zhang J., Cobb F., and Stamler J.S. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci U S A 104 (2007) 17058-17062
44. Nielsen H.J., Reimert C.M., Pedersen A.N., et al. Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion 36 (1996) 960-965